Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.40 |
| ▸ | CA1 | P00915 | 4/20 | 0.40 |
| ▸ | CA9 | Q16790 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP3 | P08254 | 1/20 | 0.38 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL1535791 | 0.98 | CA12 (0.39) | CA12CA1CA9ALDH1A1ALDH2 | |
| Hydrochloric Acid SCHEMBL25406791 | 0.98 | CA12 (0.39) | CA12CA1CA9ALDH1A1ALDH2 | |
| SCHEMBL17363406 | 0.98 | CA12 (0.39) | CA12CA1CA9ALDH1A1ALDH2 | |
| Hydrochloric Acid SCHEMBL17363346 | 0.96 | CA12 (0.38) | CA12CA1CA9ALDH1A1ALDH2 | |
| SCHEMBL5878882 | 0.91 | CA12 (0.45) | CA12CA1CA9ALDH1A1ALDH2 | |
| Hydrochloric Acid SCHEMBL25406673 | 0.91 | CA12 (0.41) | CA12CA1CA9ALDH1A1ALDH2 | |
| Hydrochloric Acid SCHEMBL25324973 | 0.90 | CA12 (0.44) | CA12CA1CA9ALDH1A1ALDH2 | |
| Acetic Acid SCHEMBL23853010 | 0.89 | CA1 (0.41) | CA12CA1CA9ALDH1A1ALDH2 | |
| SCHEMBL20527595 | 0.88 | CA12 (0.44) | CA12CA1CA9ALDH1A1ALDH2 | |
| SCHEMBL8716918 | 0.86 | CA12 (0.39) | CA12CA1CA9ALDH1A1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2292627-B1 | Aqueous catalytic process for the preparation of thiocarboxylate silane | MOMENTIVE PERFORMANCE MAT INC (US) | 2016-03-30 | — | — | EP | claimed |
| EP-1869057-B1 | AQUEOUS CATALYTIC PROCESS FOR THE PREPARATION OF THIOCARBOXYLATE SILANE | MOMENTIVE PERFORMANCE MAT INC (US) | 2012-12-19 | — | — | EP | claimed |
| EP-1960408-B1 | PROCESS FOR THE PRODUCTION OF MERCAPTOALKYLALKOXYSILANES | MOMENTIVE PERFORMANCE MAT INC (US) | 2011-07-20 | — | — | EP | claimed |
| US-5726856-A | Hexasubstituted guanidinium salts and ultracapacitors employing them as electrolytes | GENERAL ELECTRIC COMPANY (US) | 1998-03-10 | — | — | US | claimed |
| US-20150380168-A1 | THIN-LAYER CAPACITORS WITH LARGE SCALE INTEGRATION | SIEMENS AKTIENGESELLSCHAFT (DE) | 2015-12-31 | — | — | US | disclosed |
| US-7439395-B2 | Process for the preparation of guanidinium salts | MERCK PATENT GMBH (DE) | 2008-10-21 | — | — | US | disclosed |
| US-20070135645-A1 | Process for the preparation of guanidinium salts | MERCK PATENT GMBH (DE) | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135645-A1 | Process for the preparation of guanidinium salts | GMPS, AGPS, PFAS | CA12 3861/4885CA1 2824/4885CA9 1318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.